Company: IMRX
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001790340-25-000135
Chunk: 377

Company: Immuneering Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 377
---
9 %IMM-6-415293 1,212 (919)(75.8)%Other programs1,674 1,165 509 43.7 %Indirect research and development expenses:Employee-related costs2,820 3,138 (318)(10.1)%Stock-based compensation expense602 715 (113)(15.8)%Facilities and other expenses328 370 (42)(11.4)%Depreciation/amortization60 61 (1)(1.6)%Total research and development$10,868 $11,253 $(385)(3.4)%

Research and development expenses decreased by approximately $0.4 million, or 3.4%, to approximately $10.9 million for the three months ended September 30, 2025, as compared to approximately $11.3 million for the three months ended September 30, 2024. The decrease of approximately $0.4 million was primarily due to a decrease in indirect research and development expenses of approximately $0.5 million, offset by an increase of approximately $0.1 million related to direct research and development expenses. The decrease in indirect costs were primarily driven by decreased employee-related costs (including due to a lower employee headcount) of $0.3 million, stock-based compensation costs of $0.1 million, in addition to depreciation/amortization and facilities and other expenses of $43 thousand. The increase in direct costs was driven by a $0.5 million increase in expenses related to atebimetinib (IMM-1-104) and increased preclinical spend of approximately $0.5 million, offset by a $0.9 million decrease in expenses related to IMM-6-415 due to the Company's prioritization of atebimetinib. 

33

Table of Contents

General and Administrative

The following table summarizes the components of our general and administrative expenses for the periods indicated:

Three Months Ended September 30,Change20252024$% (in thousands, except percentages)Employee-related costs$2,073 $2,057 $16 0.8 %Stock-based compensation expense854 926 (72)(7.8)%Professional fees774 695 79 11.4 %Facilities and other allocated expenses57 68 (11)(16.2)%Other747 268 479 178.7 %Total general and administrative$4,505